NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 10149.00 -96.25 -0.94%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bayer AG (BIT: BAY)

 

BAY Share Price

Open 113.00 Change Price %
High 114.20 1 Day 1.10 0.97
Low 113.00 1 Week 0.00 0.00
Close 114.20 1 Month -2.70 -2.31
Volume 315 1 Year 20.65 22.07
52 Week High 123.80
52 Week Low 86.10
 
BAY Technical Analysis
3
As on 1st Nov 2017 BAY Share Price closed @ 114.20 and we RECOMMEND Buy for LONG-TERM with Stoploss of 108.90 & Buy for SHORT-TERM with Stoploss of 112.15 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 
BIT Italy Most Active Stocks
RN 0.04 0.00%
PMI 0.36 0.00%
TIT 0.75 1.35%
ISP 2.89 0.00%
F 6.94 -2.12%
TIS 0.04 0.00%
SPM 3.80 5.26%
ENEL 5.39 1.32%
TITR 0.62 1.64%
CRG 0.21 0.00%
 
BIT Italy Top Gainers Stocks
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
AE 0.50 8.70%
AE 0.50 8.70%
DIS 0.28 7.69%
DIS 0.28 7.69%
DIS 0.28 7.69%
DIS 0.28 7.69%
 
BIT Italy Top Losers Stocks
ME 0.09 -10.00%
ME 0.09 -10.00%
FTL 3.65 -7.36%
TBS 1.64 -6.82%
STEF 0.19 -5.00%
POPR 0.59 -4.84%
BIM 0.65 -4.41%
BIM 0.65 -4.41%
ZUCR 0.24 -4.00%
S24 1.70 -3.95%
 
 
BAY
Daily Charts
BAY
Intraday Charts
BAY
Free Analysis
Premium
Service
 
BAY Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE115.31
RESISTANCE114.85
SUPPORT113.55
SUPPORT113.09
SUPPORT0.00
SUPPORT0.00
 
BAY Target for Month October
4th UP TARGET136.5
3rd UP TARGET128.9
2nd UP TARGET124.2
1st UP TARGET119.5
1st DOWN TARGET106.1
2nd DOWN TARGET101.4
3rd DOWN TARGET96.7
4th DOWN TARGET89.1
 
BAY Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
BAY Target for Year 2018
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
BAY Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.bayer.com
 
BAY Address
BAY
Kaiser-Wilhelm-Allee 1
Leverkusen, 51368
Germany
Phone: 49 214 301
 
BAY Latest News
 
Your Comments and Response on Bayer AG
 
BAY Business Profile
Bayer Aktiengesellschaft develops, produces, and markets health care and agricultural products, and high-tech polymer materials worldwide. The company operates through HealthCare, CropScience, and MaterialScience segments. The HealthCare segment offers prescription pharmaceuticals, such as contraceptives, hemophilia treatments, anticoagulants, and medicines to treat multiple sclerosis, cancer, hypertension, and infectious diseases; and consumer health products comprising over-the-counter medications, dermatology products, nutritional supplements, veterinary medicines, and animal grooming products. This segment also provides medical care products, including blood glucose monitoring devices, such as single-strip and multi-strip systems; USB meters that feature integrated diabetes management software and direct plug-in to computers; contrast agent injection systems for diagnostic and therapeutic medical procedures in computed tomography, magnetic resonance imaging, and molecular imaging; and mechanical systems for removing thrombi from blood vessels, as well as service products for its systems. The CropScience segment offers products for use in agriculture as insecticides, fungicides, and herbicides or seed treatments; seeds and plant traits; and various products for gardens, green industry, and nonagricultural pest control. The MaterialScience segment provides high-tech polymer materials in the areas of polyurethanes, polycarbonates, coating and adhesive raw materials, and functional films; and produces and markets inorganic basic chemicals. The company has a strategic alliance with OncoMed Pharmaceuticals, Inc. to develop drugs to target cancer stem cell therapeutics. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
 
2005-2018 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service